Inhibition of epidermal growth factor‐induced DNA synthesis by tyrosine kinase inhibitors
- 29 January 1990
- journal article
- Published by Wiley in FEBS Letters
- Vol. 260 (2) , 198-200
- https://doi.org/10.1016/0014-5793(90)80102-o
Abstract
We prepared methyl 2,5‐dihydroxycinnamate as a stable analogue of erbstatin, a tyrosine kinase inhibitor. This analogue was about 4 times more stable than erbstatin in calf serum. It inhibited epidermal growth factor receptor‐associated tyrosine kinase in vitro with an IC50 of 0.15 . It also inhibited in situ autophosphorylation of epidermal growth factor receptor in A431 cells. Methyl 2,5‐dihydroxycinnamate was shown to delay the S‐phase induction by epidermal growth factor in quiescent normal rat kidney cells, without affecting the total amount ofDNA synthesis. The effect of erbstatin on S‐phase induction was smaller, possibly because of its shorter life time.Keywords
This publication has 8 references indexed in Scilit:
- Kinetic studies of tyrosine kinase inhibition by erbstatin.The Journal of Antibiotics, 1987
- Inhibition of tyrosine protein kinase by synthetic erbstatin analogs.The Journal of Antibiotics, 1987
- Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.The Journal of Antibiotics, 1986
- Bestatin, a microbial aminopeptidase inhibitor, inhibits DNA synthesis induced by insulin or epidermal growth factor in primary cultured rat hepatocytes.The Journal of Antibiotics, 1985
- Changes in calmodulin and its mrna accompany reentry of quiescent (G0) cells into the cell cycleCell, 1984
- Calmodulin and the cell cycle: Involvement in regulation of cell-cycle progressionCell, 1982
- Reversible G1 arrest of a human Burkitt lymphoma cell line(Raji) induced by tunicamycinBiochemical and Biophysical Research Communications, 1980
- Epidermal growth factor stimulates phosphorylation in membrane preparations in vitroNature, 1978